BBLG · NASDAQ
Bone Biologics (BBLG) Stock Price & Fundamentals
Bone Biologics (BBLG) closed at $903.25 on Oct 9, 2026, up 0.88% from the previous close of $895.39.
Share price, past year
1Y +20.82%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $903.25 |
| Sep 30, 2026 | $883.37 |
| Aug 31, 2026 | $837.38 |
| Jul 31, 2026 | $856.19 |
| Jun 30, 2026 | $850.01 |
| May 29, 2026 | $859.93 |
| Apr 30, 2026 | $814.82 |
| Mar 31, 2026 | $833.03 |
| Feb 27, 2026 | $853.45 |
| Jan 30, 2026 | $857.82 |
| Dec 31, 2025 | $813.71 |
| Nov 28, 2025 | $768.30 |
| Oct 31, 2025 | $714.16 |
Key statistics
- Market cap
- $1.64B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.26
- Revenue (TTM)
- —
- Net income (TTM)
- −$2.89M
- Shares outstanding
- 1.8M
- Dividend yield
- —
- 52-week range
- $690.44 – $903.25
Bone Biologics's market cap is $1.64B, based on a share price of $903.25 and 1.8M shares outstanding as of Jun 30, 2026.
Financials
Bone Biologics reported revenue of $1.07B for fiscal 2020, unchanged 0.00% from fiscal 2019.
Bone Biologics reported a net loss of $3.11M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2020ended Dec 31, 2020 | $1.07B | 0.0% | −$1.82M | −0.2% | −$0.63 | — |
| FY2019ended Dec 31, 2019 | $1.07B | 0.0% | −$3.42M | −0.3% | −$0.47 | — |
| FY2016ended Dec 31, 2016 | $1.07B | — | −$25.88M | −2.4% | −$0.69 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2021ended Mar 31, 2021 | $1.07B | — | — |
| Q1 FY2020ended Mar 31, 2020 | $1.07B | — | — |
Company profile
- Name
- Bone Biologics Corp
- Ticker
- BBLG
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- 2 Burlington Woods Drive,, Suite 100,, Burlington, MA 01803
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001419554
Recent SEC filings
- Sep 29, 2026
- Sep 16, 2026
- Aug 14, 2026
- Jul 23, 2026
- Jul 16, 2026
- Jul 9, 2026
- May 14, 2026
- Mar 13, 2026
Frequently asked questions
What is Bone Biologics's stock price?
Bone Biologics (BBLG) closed at $903.25 on Oct 9, 2026, up 0.88% from the previous close of $895.39.
What is Bone Biologics's market cap?
Bone Biologics's market cap is $1.64B, based on a share price of $903.25 and 1.8M shares outstanding as of Jun 30, 2026.
How much revenue does Bone Biologics make?
Bone Biologics reported revenue of $1.07B for fiscal 2020, unchanged 0.00% from fiscal 2019.
Does Bone Biologics pay a dividend?
Bone Biologics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Bone Biologics Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures